Publicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (21)

2024

  1. Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA

    Clinical Gastroenterology and Hepatology, Vol. 22, Núm. 11, pp. 2280-2290

2023

  1. Paediatric intensive care ‘do not do’ recommendations in Spain: Selection by Delphi method

    Anales de Pediatria, Vol. 98, Núm. 1, pp. 28-40

2022

  1. Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients

    Frontiers in Medicine, Vol. 9

  2. Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study

    Inflammatory bowel diseases, Vol. 28, Núm. 11, pp. 1725-1736

  3. Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry

    Journal of Clinical Medicine, Vol. 11, Núm. 2

  4. Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case–Control Study (COVID-19-EII)

    Journal of Clinical Medicine, Vol. 11, Núm. 24

2020

  1. Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients with Inflammatory Bowel Disease: Results from the Eneida Registry

    Inflammatory Bowel Diseases, Vol. 26, Núm. 4, pp. 606-616

  2. Update of the hyperglycemia Gestational diagnosis during the COVID-19 pandemic

    Endocrinologia, Diabetes y Nutricion, Vol. 67, Núm. 8, pp. 545-552

  3. Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Clinical and molecular diagnosis of non-phosphomannomutase 2 N-linked congenital disorders of glycosylation in Spain

    Clinical Genetics, Vol. 95, Núm. 5, pp. 615-626

  2. Quantification of urinary derivatives of Phenylbutyric and Benzoic acids by LC-MS/MS as treatment compliance biomarkers in Urea Cycle disorders

    Journal of pharmaceutical and biomedical analysis, Vol. 176, pp. 112798

2017

  1. Evolution after Anti-TNF Discontinuation in Patients with Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study

    American Journal of Gastroenterology, Vol. 112, Núm. 1, pp. 120-131

2016

  1. Incidence, clinical characteristics, and management of psoriasis induced by Anti-TNF therapy in patients with inflammatory bowel disease: A nationwide cohort study

    Inflammatory Bowel Diseases, Vol. 22, Núm. 4, pp. 894-901

2012

  1. Can an intervention on clinical inertia have an impact on the perception of pain, functionality and quality of life in patients with hip and/or knee osteoarthritis? Results from a cluster randomised trial

    Atencion Primaria, Vol. 44, Núm. 2, pp. 65-72

2010

  1. Clinical experience with miglustat therapy in pediatric patients with Niemann-Pick disease type C: A case series

    Molecular Genetics and Metabolism, Vol. 99, Núm. 4, pp. 358-366

2009

  1. Recomendaciones para el cuidado y atención del recién nacido sano en el parto y en las primeras horas después del nacimiento

    Anales de Pediatria, Vol. 71, Núm. 4, pp. 349-361

  2. Retinopathy of prematurity. Prevention, screening and treatment guidelines

    Anales de Pediatria, Vol. 71, Núm. 6, pp. 514-523

2006

  1. Erratum: Evaluation of the effectiveness and clinical security of Menopur® in the ovarian stimulation in IVF-ICSI (Revista Iberoamericana de Fertilidad y Reproduccion Humana)

    Revista Iberoamericana de Fertilidad y Reproduccion Humana

  2. Evaluación de la efectividad y seguridad clínica de Menopur® en la estimulación de la ovulación en ciclos de FIV-ICSI

    Revista Iberoamericana de Fertilidad y Reproduccion Humana, Vol. 23, Núm. 4, pp. 245-255

2001

  1. Nutrición enteral pediátrica a domicilio: Revisión práctica

    Pediatrika, Vol. 21, Núm. SUPPL. 3, pp. 5-21